Cervical cancer

Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) Jg. 393; H. 10167; S. 169 - 182
Hauptverfasser:	Cohen, Paul A, Jhingran, Anjua, Oaknin, Ana, Denny, Lynette
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Elsevier Ltd 12.01.2019 Elsevier Limited
Schlagworte:	Bevacizumab Cancer Cervical cancer Cervix Chemoradiotherapy Female Fertility Global Health Health risk assessment Healthcare Disparities - statistics & numerical data HIV Human immunodeficiency virus Human papillomavirus Humans Hysterectomy Immunotherapy Incidence Income Mass Screening - methods Mass Screening - statistics & numerical data Metastases Monoclonal antibodies Mortality Neoplasm Staging Papillomavirus Infections - epidemiology Papillomavirus Vaccines - immunology Poverty Radiation therapy Risk Factors Screening Solid tumors Targeted cancer therapy Toxicity Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - therapy Vaccination Vaccines Vascular endothelial growth factor Viruses Womens health United States > US South Africa Africa
ISSN:	0140-6736, 1474-547X, 1474-547X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!